Bio-Techne Corp (FRA:TE1)
€ 76.5 1 (1.32%) Market Cap: 11.96 Bil Enterprise Value: 12.28 Bil PE Ratio: 65.48 PB Ratio: 6.45 GF Score: 92/100

Bio-Techne Corp at Barclays Global Healthcare Conference Transcript

Mar 13, 2019 / 01:00PM GMT
Release Date Price: €42.66 (+0.84%)
Jack Meehan
Barclays Bank PLC, Research Division - VP & Senior Research Analyst

And welcome to our second presentation in the morning. I'm in tool land. I'm Jack Meehan, the Barclays life science tools and diagnostics analyst. Pleased to be joined by Bio-Techne and the company's CFO, Jim Hippel. Quickly we're going to do some audience response questions so use the BlackBerry devices in front of you. First question, what do you view as Bio-Techne's organic growth over the next 3 years?

(Voting)

Jack Meehan
Barclays Bank PLC, Research Division - VP & Senior Research Analyst

You can give us the answer later in the presentation. So leaning toward high single digits and then a mix in double.

Question #2. How confident are you in the outlook for growth in China?

(Voting)

Jack Meehan
Barclays Bank PLC, Research Division - VP & Senior Research Analyst

So from very confident to not at all confident. More uncertain, I would say, kind of a mix. And then finally, how would you like

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot